Biodrugs

Biodrugs英文简介

An essential resource for R&D professionals and clinicians with an interest in biologic therapies.

BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.

BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager?, supported by a database of international experts. This database is shared with other Adis journals.

Biodrugs中文简介

《Biodrugs》是一本由ADIS INT LTD出版商出版的专业医学期刊，该刊创刊于1994年，刊期Bimonthly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：免疫学 3区；肿瘤学 3区；药学 3区；在JCR（Journal Citation Reports）分区等级为Q1。该刊发文范围涵盖免疫学等领域，旨在及时、准确、全面地报道国内外免疫学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为7.744，平均审稿速度>12周，或约稿。

中科院分区最新升级版（当前数据版本：2021年12月最新升级版）

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	3区	PHARMACOLOGY & PHARMACY 药学 IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学	2区 3区 3区	否	否

JCR分区（当前数据版本：2021-2022年最新版）

JCR分区等级	JCR所属学科	分区	影响因子
Q1	ONCOLOGY	Q1	7.744
	PHARMACOLOGY & PHARMACY	Q1
	IMMUNOLOGY	Q1

期刊指数

影响因子	h-index	Gold OA文章占比	研究类文章占比	OA开放访问	平均审稿速度
7.744	60	45.83%	61.70%	未开放	>12周，或约稿

IF值(影响因子)趋势图